Lott J A
Department of Pathology, The Ohio State University Medical Center, Columbus 43210, USA.
Scand J Clin Lab Invest. 1999 Nov;59(7):527-30. doi: 10.1080/00365519950185283.
With the advent of much more precise laboratory equipment, the use of performance-based standard deviations for enzymes, e.g. those based on the precision of the laboratory during a period of "satisfactory performance", is not appropriate; it leads to overly rigid precision limits and unnecessary repeat assays, and is wasteful of resources. Testing for the commonly used serum enzymes does not require tight precision given how enzyme data are viewed by most clinicians. Other ways to set process control limits all have some arbitrary content; however, this need not prevent their use. Laboratorians must choose the approach that is appropriate for their laboratory and medical staff to meet medically perceived needs.
随着更加精确的实验室设备的出现,使用基于性能的酶的标准差,例如基于实验室在“满意性能”期间的精密度的标准差,是不合适的;它会导致过于严格的精密度限制和不必要的重复检测,并且浪费资源。考虑到大多数临床医生对酶数据的看法,对常用血清酶进行检测并不需要严格的精密度。设置过程控制限的其他方法都有一些随意性内容;然而,这并不妨碍它们的使用。实验室工作人员必须选择适合其实验室和医务人员的方法,以满足医学上可感知的需求。